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Abstract
Background: Skin erythemas of unknown origin are a frequent reason for consulting the general practitioner or
dermatologist.
Case presentation: Here we report a case of an erythema resembling the erythema migrans manifestation of
Lyme disease, but with atypical symptoms like persistent pruritus. The patient had no history of a recent tick-bite
but displayed a positive serology for an advanced stage of Lyme borreliosis, which stood in contrast to the clinical
manifestation of erythema migrans as a symptom of early Lyme disease. Three skin swabs and soil samples,
collected in the area where the patient possibly acquired the infection, were examined by bacterial and fungal
culture methods. Microorganisms were identified by using 16 S rRNA gene sequencing and bioinformatics. The
patient and soil isolates were compared by employing RAPD analysis. The serum samples of the patient were
examined by immunoblotting. Arthrobacter mysorens, a soil bacterium, was isolated from the collected skin and soil
samples. The identity of both isolates was determined by molecular fingerprinting methods. A. mysorens was
proven to be causative for the erythema by direct isolation from the affected skin and a positive serology, thus
explaining the atypical appearance of the erythema compared to erythema migrans caused by Borrelia infection.
Conclusions: Infections with A.mysorens might be underreported and microbiological diagnostic techniques
should be applied in cases of patients with unclear erythemas, resembling erythema migrans, without a history of
tick bites.
Background
Skin erythemas of unknown origin are a frequent reason
for consulting the general practitioner or dermatologist.
Among many clinicians, laminary spreading erythemas
often lead to the diagnosis of a tick bite-associated
erythema migrans (EM), a symptom of early localized
infection with Borrelia burgdorferi (sensu lato) [1,2]. As
the development of an immunologic response to this
infection usually takes 4 to 6 weeks and the incubation
period for EM is typically 7 to 14 days, early Lyme bor-
reliosis often presents itself with a negative serology
[3,4]. In addition, tick bites are not always described or
remembered by the patient. Thus, the diagnosis is
mostly based on clinical symptoms. In its typical appear-
ance, EM is a homogenous spreading, indolent, erythe-
matous, oval shaped lesion with a bright red border and
a central clearing. Minimal pruritus might be present at
an early stage. EM develops at the site of the tick bite
and therefore can be located on any part of the body.
Mild systemic symptoms like low-grade fever and chills
might be present. EM in the United States is often asso-
ciated with more prominent signs of inflammation, as
compared to that in Europe [1-4]. This case report illus-
trates that erythemas caused by other pathogens might
resemble this clinical picture, thus a false diagnosis may
be made which may complicate and prolong the disease
process and prevent adequate therapy.
Case presentation
In June early summer, a nine-year old boy spent four
hours in a forest digging out a bicycle track to ride his
mountain bike. He returned home with a dirty shirt in
particular at the right side of the chest, very close to
the right acromastium. Since he felt a localised pruri-
tus there, he had intensively scratched the region,
thereby contaminating the skin with forest soil.
A small erythema with an average diameter of one
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centimetre and a clear-cut red edge above the right
acromastium was apparent on the following day. His
mother suspected a potential insect or tick bite,
although no tick could be found. The patient had no
previous erosion. The then conducted Borrelia-specific
ELISA was negative for IgM antibodies but positive for
IgG antibodies. An immunoblot (Recomblot Borrelia,
Mikrogen, Germany) with the patient’s serum revealed a
B. burgdorferi sensu lato-specific, IgG antibody response
to p100, p41, BmpA, OspC (weakly positive), p41, and
p18 but no IgM-specific antibody response could be
detected. This finding was consistent with a Borrelia
infection at an advanced stage (> 6 months after infec-
tion) or a residual of an earlier infection, as a symptom-
free patient may also have a similar Borrelia-specific
antibody response based on longtime persistent antibo-
dies. Clinical findings in this stage are typically those of
advanced neuroborreliosis (progressive encephalomyeli-
tis etc.), acrodermatitis chronica atrophicans or Lyme
arthritis. Since the patient did not display any symptoms
corresponding to these clinical syndromes, a residual,
asymptomatic infection was suspected and no specific
treatment was initiated. These findings argue against a
Borrelia infection as the cause for the patient’s symp-
toms, as EM caused by Borrelia burgdorferi s. l. repre-
sents a very early stage of infection [2,5,6] and would
probably lead to a specific IgM antibody response. To
exclude a possible re-infection, a second serum sample
parallel to the first sample was tested 4 weeks later.
However, no significant serological changes could be
observed. Within one week, the small erythema spread
laminarly, exhibiting a red edge with a paler, faded cen-
tre, and the patient showed symptoms resembling an
EM caused by B. burgdorferi (Figure 1) as an early
symptom of Lyme disease [1,4]. In distinction to a
typical EM with its regular, oval form, the shape of the
erythema was nearly rectangular and displayed “protuber-
ances” at the edge of the lesion (Figure 1). Thus, the clini-
cal picture, together with the serological findings did not
clearly correlate with the early clinical manifestation of
Lyme disease, namely EM [2,3]. Since the patient com-
plained about a persistent pruritus, which is atypical in
EM (where minimal pruritus is only occasionally described
at an early stage), a dermal mycosis was suspected, leading
to the prescription of a topical antimycotic drug solution
with the active component Econazol (Janssen Cilag
GmbH, Neuss, Germany) by the family physician. The
treatment proved to be ineffective since the erythema
showed clinical progression and started to cover the com-
plete right chest, neck and shoulder. It still presented a
clear erythematous edge and a faded centre (Figure 1).
At this point, the family consulted the Institute of
Medical Microbiology (Giessen, Germany) and as part
of a staged diagnostic approach, three swabs of the skin
were taken simultaneously from different localisations;
the first one from the initial focus of infection, the sec-
ond one from the edge of the erythema and the third
one approximately 50 millimetres outside the visible
edge. The swabs were cultured for fungi and bacteria.
The culture on sheep blood agar plates from swab one
and two revealed many yellow-pigmented small colonies
at room temperature after 48 hours of incubation. After
72 to 96 hours, the colonies showed a frayed edge indi-
cating motile bacteria (Figure 2). These colonies could
not be demonstrated in the culture of the third swab
from the outside of the erythema. Additionally, few Sta-
phyloccus epidermidis colonies, as members of the indi-
genous skin flora, could be found in all the three swab
samples. No fungal growth could be evidenced even
after prolonged incubation of 4 weeks, which argues
against the presence of dermatophytes. The yellow-
pigmented colonies did not grow at 37°C in the pre-
sence or absence of CO2. The partial sequencing of the
16 S rRNA gene and data base analysis using the
BLAST algorithm (NCBI) and the SepsiTest™ BLAST
http://www.sepsitest-blast.de identified the isolate as
Arthrobacter mysorens (GeneBank accession number
HM751094). Biochemical assays using API systems (Bio-
Merieux, Nuertingen, Germany) demonstrated only the
genus Arthrobacter but not the species. Antibiotic sus-
ceptibility testing via agar diffusion method and E-Test,
classified the isolate to be susceptible against amoxicil-
lin, doxycycline, cefuroxime, ceftriaxone, and cefotaxime
(MIC’s < 0.064 mg/ml). The patient was thereafter
successfully treated with oral amoxicilline for one week
(3 × 1 g per day). The skin erythema showed significant
clinical improvement and was no longer detectable
within two days. Subsequent swab analysis remained
negative for Arthrobacter mysorens. To further
Figure 1 Erythema on the patient’s chest. The black dot
indicates the initial focus of the erythema, the arrow heads the
periphery of the lesion. Arthrobacter mysorens was isolated from the
black dot area and from the red edge close to the arrow heads.
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determine the role of A. mysorens an immunoblot analy-
sis using a whole cell extract of A. mysorens was per-
formed. The patient’s serum showed a specific immune
response against a ~53-kDa and a ~32-kDa protein,
respectively (Figure 2D), which demonstrates that the
immune system responded to A. mysorens with a type-
specific response. A control Borrelia serology after
6 months demonstrated a loss of the OspC and p18
bands and a weakened intensity of the BmpA band in
the IgG-immunoblot, thus indicating a diminishing
immune response and supporting the initial theory of a
residual antibody response reflecting a past infection.
The genus Arthrobacter includes a heterogenous group
of aerobic, gram-positive, catalase-positive, non-fermen-
tative coryneform bacteria that are widely distributed in
the environment where their main habitat is the soil.
Cells are able to resist desiccation and starvation [7].
From a review of the literature only about 42 documen-
ted cases of Arthrobacter species isolated from clinical
samples could be retrieved [8].
Conclusions
To our knowledge, this is the first documented case of a
skin infection with A. mysorens, probably reflecting a
new relevant human clinical isolate of this genus. In
order to identify the possible source of the infection, we
collected forest soil samples (n = 50) from the area
where the infection most likely occurred and could
indeed isolate A. mysorens from one sample. Randomly
amplified polymorphic DNA (RAPD) analysis using two
different primers revealed clonal identity between the
soil and the skin isolate (Figure 2A) [9]. Therefore, the
localised skin infection caused by this particular soil
bacterium was likely to be caused by contamination
with forest soil. The mobile pathogen (Figure 2) seems
to be capable of epidermal spread and could be detected
only in the centre and at the edge of the erythema (Fig-
ure 1). Arthrobacter species have been occasionally iso-
lated from patients with immunodeficiencies [7].
Furthermore, Arthrobacter species have been described
as microbial allergens which can cause allergic reactions
Figure 2 Analysis of Arthrobacter mysorens. A) Randomly amplified polymorphic DNA (RAPD) analysis of the clinical isolate (lane 1) and the
soil isolate (lane 2) using primer P1 [5’-GGTGCGGGAA-3’] and primer P5 [5’-AACGCGCAAC-3’]. The analyses were done with the “Ready To Go
RAPD analysis beads” test kit from Pharmacia (Fribourg, Germany). B) Yellow-pigmented A. mysorens clinical isolates grown on sheep blood agar
plates after an incubation period of 72 hours at room temperature. C) Scanning electron microscopy of A.mysorens clinical isolates. Magnification:
30,000 ×. D) Immunoblot analysis of the patient’s serum using a whole cell extract of A. mysorens clinical isolate. Arrow heads indicate the two
reacting proteins of ~53-kDa and ~32-kDa, respectively.
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in furniture factory workers and in people occupation-
ally exposed to herbal dust [10,11]. The ability of
Arthrobacter species to cause allergic reactions is a plau-
sible explanation for the clinical symptom of pruritus
described by the patient.
Because of the difficulties in culturing and identifying
Arthrobacter isolates by conventional culture methods
and biochemical assays, it is likely that infections with
these coryneform bacteria are underreported, especially
as the standard treatment regime for EM (doxycyline,
amoxicillin, cefuroxime axetil) would also treat Arthro-
bacter infections. Cultivation of these bacteria was possi-
ble by using incubation at room temperature, which is
in general not performed or recommended for these
types of samples. Therefore, we advise incubation at
room temperature and prolonged incubation for the
bacterial culture of skin samples derived from erythema
and, in case of bacterial growth the use of molecular
diagnostic techniques like 16 S rRNA gene sequencing
or MALDI-TOF MS for the identification of unusual
bacterial isolates. This report shows the importance of
clearly distinguishing such an infection from the well-
described early manifestation of Lyme disease, namely
EM, after a tick bite.
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